Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma

Clinical trial NCT07285590 · RECRUITING

Trial details

NCT number: NCT07285590
Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma (MCL)

Start date: 2025-09-30
Primary completion: 2032-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.